Back to Journals » OncoTargets and Therapy » Volume 6

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

Total article views   HTML views PDF downloads Totals
17,460 Dovepress* 12,313+ 3,396 15,709
PubMed Central* 5,147 1,812 6,959
Totals 17,460 5,208 22,668
*Since 5 November 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 0 5

View citations on PubMed Central and Google Scholar